Kathleen Sanzo is the leader of the FDA practice at Morgan Lewis and leader of the firm’s life sciences industry initiative. She centers her practice on regulatory and compliance issues connected to products regulated by the US Food and Drug Administration (FDA). She leads and counsels clients on matters relating to prescription, OTC drug, and biotechnology products clinical testing; food, dietary supplement, and cosmetic product manufacture, approval, marketing, and distribution; device promotion and labeling issues; food, drug, and device compliance matters; and all consumer product issues regulated by the US Consumer Product Safety Commission (CPSC) and state enforcement agencies. Kathleen represents clients in the pharmaceuticals and biotechnology, food and dietary supplements, consumer products, consumer protection safety, advertising, cosmetics, drugs, and medical industries. For more information, please view her bio at https://www.morganlewis.com/bios/ksanzo.
Duke University, 1979, A.B.; Emory University School of Law, 1982, J.D.; The George Washington University Law School, 1985, LL.M.